Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic inflammatory demyelinating polyradiculoneuropathy.

Ted M Burns1

  • 1University of Virginia Department of Neurology, Charlottesville, VA 22908, USA.

Archives of Neurology
|June 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.

Translational neurodegeneration·2025
Same author

Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU).

Muscle & nerve·2023
Same author

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events.

PloS one·2022
Same author

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

Neurology·2021
Same author

Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.

EMBO molecular medicine·2020
Same author

Rising Drug Costs for Neurologic Diseases.

Continuum (Minneapolis, Minn.)·2020
Same journal

Incorrect Table Entries and Word.

Archives of neurology·2016
Same journal

IDEAL for CCSVI Research-Reply.

Archives of neurology·2013
Same journal

Atlas of Inherited Metabolic Diseases, 3rd ed.

Archives of neurology·2013
Same journal

Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

Archives of neurology·2013
Same journal

This month in archives of neurology.

Archives of neurology·2013
Same journal

About this journal.

Archives of neurology·2013
See all related articles

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) was poorly understood for decades due to varied naming and diagnostic challenges. Advances in research and treatment options like corticosteroids have since clarified CIDP as a distinct neurological disorder.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) was historically misidentified and poorly understood.
  • Limited diagnostic tools and research hindered progress in comprehending CIDP throughout much of the 20th century.

Observation:

  • Mid-20th century saw key advancements, including the development of the experimental allergic neuritis (EAN) model.
  • Emergence of nerve conduction studies and discovery of corticosteroids significantly impacted CIDP research.
  • By the 1970s, CIDP was recognized as a distinct entity with specific clinical, histopathological, and electrodiagnostic characteristics.

Findings:

  • Diagnostic criteria for CIDP were established, enabling clearer identification.
  • Treatment trials confirmed the effectiveness of corticosteroids, plasma exchange, and intravenous immunoglobulin for CIDP management.

Related Experiment Videos

Implications:

  • The distinct classification of CIDP has improved diagnostic accuracy and patient care.
  • Established treatment protocols offer effective management strategies for individuals with CIDP.
  • Continued research into CIDP pathogenesis and therapeutic interventions remains crucial for advancing patient outcomes.